MD-PhD (Docteur d'Etat - Sciences), professor in biochemistry at Université de Poitiers, France
Director Inserm U927 (formerly ERM324) : Ischemia-reperfusion and renal transplantation.
Vice Director (Poitiers site) Doctoral School Bio-santé ED524., PRES Limousin-Poitou-Charentes.
In charge for PRES Poitou-Charentes of collaborative projects “biology applied to health” for the Franco-Indonesian Cooperation in Higher Education
Formerly at Université Paul Sabatier, Toulouse France
since 1975 (assistant-professor, then MCU-PH)
Inserm U101, then Inserm U326 (head : Pr L Douste-Blazy, then Pr H Chap) and deparment of Biochemistry and Molecular Biology (Pr H. Chap), Université P. Sabatier et Centre Hospitalier Régional, Toulouse,
Also at Temple University, Philadelphia, Pa , USA.
1983-1984 : Visiting Assistant Professor, The Specialized Thrombosis Research Center (Pr J.B. Smith), Health Science Center, Temple University, Philadelphia, USA. and 1985: Visiting Research Scientist, Department of Pharmacology (Pr L. Salganicoff), School of Medicine, Temple University, Philadelphia, USA.
- signal transduction and metabolism of inositol lipids, mainly in activated platelets. Role of thrombin, PAF-acether, ADP and concanavalin A ; role of protein phosphorylation and of phospholipids in organizing signal transduction particles and their relationships with cytoskeleton reorganization..
- signal transduction during organ / cell cold preservation,
- implications of coagulation proteases and their inhibition for kidney grafting, design of new preservation solutions and protocols for organ transplantation, potential use of several stem cell-lines for organ transplantation.